Estimating treatment benefits of hormone therapy for men with prostate cancer
Individualized estimates of treatment benefit from hormone therapy for men with prostate cancer
This study is looking to help men with localized prostate cancer understand how hormone therapy might work for them by considering their unique health situations and backgrounds, so they can make better choices about their treatment.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10739866 on NIH RePORTER |
What this research studies
This research aims to create personalized estimates of treatment benefits from hormone therapy for men diagnosed with localized prostate cancer. By analyzing data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial, the study focuses on understanding how other health conditions and demographics influence life expectancy and treatment outcomes. The goal is to develop a model that helps doctors and patients make informed decisions about hormone therapy based on individual risk factors and potential benefits.
Who could benefit from this research
Good fit: Ideal candidates for this research are men diagnosed with localized prostate cancer who are considering hormone therapy as part of their treatment.
Not a fit: Patients with advanced prostate cancer or those who are not considering hormone therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more tailored treatment plans for men with prostate cancer, improving their quality of life and survival rates.
How similar studies have performed: Previous research has shown promise in developing individualized treatment models for cancer patients, indicating that this approach could be effective.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Schipper, Matthew — University of Michigan at Ann Arbor
- Study coordinator: Schipper, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.